Summit Trail Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Summit Trail Advisors, LLC
- $7.06 Billion
- Q3 2025
A detailed history of Summit Trail Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 18,550 shares of CRL stock, worth $3.11 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
18,550
Previous 14,443
28.44%
Holding current value
$3.11 Million
Previous $2.19 Million
32.45%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
646Shares Held
51.6MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...